NCT03988686

Testing Radical Prostatectomy in Chinese Men With Prostate Cancer and oligoMetastases to the Bone

Zhongshan Hospital, Fudan University

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 120 (estimated)
• Sponsor: Fudan University · Academic / Other
• Sex: Male
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This study is to examine whether radical prostatectomy can impact survival and quality-of-life in men with oligo-metastatic prostate cancer.

Detailed description

In this study, patients with oligo-metastatic prostate cancer will be randomized to radical prostatectomy plus standard care and standard care only. Standard care refers to androgen deprivation therapy (ADT) +/- other systemic therapies. Time to disease progression and post-treatment quality of life will be assessed and compared.

Conditions

• Prostate Cancer Metastatic

Interventions

Type	Name	Description
PROCEDURE	Radical prostatectomy plus standard care	To add radical prostatectomy on the basis of current standard of care for those with oligometastatic prostate cancer
DRUG	Standard of care for metastatic prostate cancer	androgen deprivation therapy with or without other systemic therapies based on current guidelines for metastatic prostate cancer

Timeline

• Start date: 2019-04-01
• Primary completion: 2021-03-31
• Completion: 2022-03-31
• First posted: 2019-06-17
• Last updated: 2019-06-17

Locations

1 site across 1 country: China